Politics and Policy

Payers’ biggest concerns for 2018, health insurance exchange participation plans, and how offerings could change.

FDA incentives have hastened the development of “orphan drugs” for rare diseases, but some worry that regulators are not always demanding clear evidence for drug efficacy.

External, non-payer generated data can inform formulary decision-making-if payers know their strengths and weaknesses.

The specialty drugs market will see more approvals in 2017 than 2016. Top areas to watch include cancer, multiple sclerosis, and HIV.

Trump takes two steps to dissolve the ACA. Find out what the experts think about these two important actions.

Here’s a quick guide to the meaning behind Trump’s executive order and decision to stop cost-sharing reduction payments.

Recently, FDA Commissioner Scott Gottlieb announced the FDA will move to close loopholes in the Orphan Drug Program. Here’s what you need to know.

New healthcare terms and topics constantly crop up. Here are six to keep an eye on right now.

New physician-administered therapies on the horizon may help rein in the opioid epidemic.

Between 1990 and 2013, the maternal mortality ratio more than doubled in the United States. Find out what experts say can resolve the issue.

Now that the Graham-Cassidy bill has failed, here’s what healthcare executives should do to plan for 2018.

In the wake of the failure of the Graham-Cassidy bill, experts share what’s ahead for health policy.

Here are the top 10 states with the highest uninsured rate, according to personal-finance website WalletHub.

A survey of nearly 200 healthcare executives has interesting findings related to population health management.

Even before Hurricane Harvey made landfall in Texas, health insurers were prepared for the worst. Here, they discuss what steps they took before the storm hit.

Clinical experience and business acumen are important factors in a successful healthcare leader, but the ability to accept change and help an organization adapt are perhaps the most critical.

CMS’ Quality Payment Program launched in 2016 as part of MACRA. Here’s what’s in store for Year 2.

Experts share how the declaration could affect how the opioid epidemic is managed.

As President Trump declares the opioid epidemic “a national emergency,” a new opioid management program from Express Scripts will limit the number and strength of opioid drugs to first-time patients.

As legislative discussions begin regarding the reauthorization of CHIP, it is imperative to keep in mind how proposed cuts could be detrimental to the health and future of our nation’s children.

As the nation debates the future of our healthcare system, one idea gaining attention is a “Medicare-for-all” single-payer national health insurance plan.

Here’s a look at four changes in the second round of healthcare bill revisions that just weren’t enough to muster up enough votes.

In lines of care where improved outcomes aren’t paired with bonus payments, motivating providers and members to close gaps in care can be difficult.

Developing and carrying out a unified strategy for quality improvement can be difficult. CareSource is outlining its goals and supporting the front lines to initiate change.

The Stars ratings are meant to ensure that every health plan is providing adequate services for members. For payers, meeting these ever-changing measures can be a challenge.